Prevention of venous thromboembolism after right heart-sided electrophysiological procedures: results of an EHRA survey.

anticoagulation catheter ablation electrophysiological study right-sided ablations

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
13 Dec 2023
Historique:
received: 09 10 2023
accepted: 05 12 2023
medline: 14 12 2023
pubmed: 14 12 2023
entrez: 13 12 2023
Statut: aheadofprint

Résumé

Limited data are available regarding venous thromboembolism (VTE), specifically deep vein thrombosis (DVT) and pulmonary embolism (PE), following right-sided ablations and electrophysiological (EP) studies. Compared to left-sided procedures, no guidelines on antithrombotic management strategies for the prevention of DVT and PE are available. The main purpose of the present European Heart Rhythm Association (EHRA) survey is to report the current management of right-sided EP procedures, focusing on anticoagulation and prevention of VTE. An online survey was conducted using the EHRA infrastructure. A total of 244 participants answered a 19-items questionnaire on the periprocedural management of EP studies and right-sided catheter ablations.The right femoral vein is the most common access for EP studies and right-sided procedures. An ultrasound-guided approach is employed by more than 2/3 of respondents. Intravenous heparin is not commonly given by the majority of participants. About 1/3 of participants (34%) routinely prescribe VTE prophylaxis during (mostly aspirin and low molecular weight heparin) and 1/4 of respondents (25%) commonly prescribe VTE prophylaxis after discharge (mostly aspirin). Of note, respectively 13% and 9% of participants observed at least one DVT and one PE related to right-sided ablation or EP study within the last year in their center. The present survey shows that only a minority of operators routinely gives intraprocedural intravenous heparin and prescribes VTE prophylaxis after right-sided EP procedures. Compared to left-sided procedures like AF ablation, there are no consistent systematic antithrombotic management strategies.

Identifiants

pubmed: 38091971
pii: 7471799
doi: 10.1093/europace/euad364
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Giacomo Mugnai (G)

Division of Cardiology, Cardio-Thoracic Department, School of Medicine, University Hospital of Verona, Verona, Italy.

Michal Farkowski (M)

Department of Cardiology, Ministry of Interior and Administration National Medical Institute, Warsaw, Poland.

Luca Tomasi (L)

Division of Cardiology, Cardio-Thoracic Department, School of Medicine, University Hospital of Verona, Verona, Italy.

Laurent Roten (L)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Federico Migliore (F)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padova, Padova, Italy.

Carlo de Asmundis (C)

Heart Rhythm Management Centre, Universitair Ziekenhuis Brussel, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart, Vrije Universiteit Brussel, Brussels, Belgium.

Giulio Conte (G)

Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland.

Serge Boveda (S)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Julian K R Chun (JKR)

Cardioangiologisches Centrum Bethanien (CCB), Medizinische Klinik III, Agaplesion Markus Krankenhaus, Frankfurt Am Main, Germany.

Classifications MeSH